Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Blood Unpaywall

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL

Pfreundschuh, M.
Blood – Apr 8, 2004
Download PDF

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL

Pfreundschuh, M.
Blood – Apr 8, 2004

Loading next page...
 
/lp/unpaywall/two-weekly-or-3-weekly-chop-chemotherapy-with-or-without-etoposide-for-lNUBpLOkeJ

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Unpaywall
ISSN
0006-4971
DOI
10.1182/blood-2003-06-2095
Publisher site
See Article on Publisher Site

Abstract

Journal

Blood – Unpaywall

Published: Apr 8, 2004

There are no references for this article.